195 related articles for article (PubMed ID: 23334981)
1. Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10.
Sarkar S; Zhou X; Justa S; Bommireddy SR
Arthritis Rheum; 2013 Apr; 65(4):960-71. PubMed ID: 23334981
[TBL] [Abstract][Full Text] [Related]
2. Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses.
Justa S; Zhou X; Sarkar S
PLoS One; 2014; 9(3):e93279. PubMed ID: 24676270
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice.
Geboes L; Dumoutier L; Kelchtermans H; Schurgers E; Mitera T; Renauld JC; Matthys P
Arthritis Rheum; 2009 Feb; 60(2):390-5. PubMed ID: 19180498
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
[TBL] [Abstract][Full Text] [Related]
8. ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints.
Pineda MA; Rodgers DT; Al-Riyami L; Harnett W; Harnett MM
Arthritis Rheumatol; 2014 Jun; 66(6):1492-503. PubMed ID: 24497523
[TBL] [Abstract][Full Text] [Related]
9. Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4.
Sarkar S; Cooney LA; White P; Dunlop DB; Endres J; Jorns JM; Wasco MJ; Fox DA
Arthritis Res Ther; 2009; 11(5):R158. PubMed ID: 19852819
[TBL] [Abstract][Full Text] [Related]
10. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
11. Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice.
Hammaker D; Topolewski K; Edgar M; Yoshizawa T; Fukushima A; Boyle DL; Burak EC; Sah RL; Firestein GS
Arthritis Rheum; 2012 Mar; 64(3):678-87. PubMed ID: 21953132
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-34 Aggravates the Severity of Arthritis in Collagen-Induced Arthritis Mice by Inducing Interleukin-17 Production.
Zhang L; Cui M; Ding L; Xia L; Lu J; Shen H
J Interferon Cytokine Res; 2018 May; 38(5):221-225. PubMed ID: 29664689
[TBL] [Abstract][Full Text] [Related]
14. Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice.
Aarts J; Roeleveld DM; Helsen MM; Walgreen B; Vitters EL; Kolls J; van de Loo FA; van Lent PL; van der Kraan PM; Koenders MI
Rheumatology (Oxford); 2021 Apr; 60(4):1974-1983. PubMed ID: 33197269
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin D2 regulates joint inflammation and destruction in murine collagen-induced arthritis.
Maicas N; Ibáñez L; Alcaraz MJ; Úbeda A; Ferrándiz ML
Arthritis Rheum; 2012 Jan; 64(1):130-40. PubMed ID: 21898357
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated experimental arthritis in IL-33 deficient mice.
Talabot-Ayer D; Martin P; Seemayer CA; Vigne S; Lamacchia C; Finckh A; Saiji E; Gabay C; Palmer G
Cytokine; 2014 Sep; 69(1):68-74. PubMed ID: 25022964
[TBL] [Abstract][Full Text] [Related]
17. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
[TBL] [Abstract][Full Text] [Related]
19. Anti-arthritic and anti-inflammatory effects of (-)-Epicatechin-3-O-β-d-allopyranoside, a constituent of Davallia formosana.
Hsiao HB; Wu JB; Lin WC
Phytomedicine; 2019 Jan; 52():12-22. PubMed ID: 30599891
[TBL] [Abstract][Full Text] [Related]
20. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
Chen L; Wu X; Zhong J; Li D
BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
